Skip to content
2000
Volume 13, Issue 1
  • ISSN: 1573-3963
  • E-ISSN: 1875-6336

Abstract

Pediatric cancer has undergone significant improvements in survival over the past several decades, in part due to a better understanding of the underlying genetic aberrations of each oncologic diagnosis, which has allowed for more effective targeted therapies. Pediatric brain tumors, leukemia, lymphoma, Wilms tumor, and retinoblastoma are exemplary pediatric cancers that each has specific epidemiology regarding children at risk as well as characteristic associated genetic lesions. These genetic features are more commonly being used to provide risk stratification, as well as to identify novel pathways for targeted therapy. With these advances, the overall survival of pediatric cancers continues to be improved.

Loading

Article metrics loading...

/content/journals/cpr/10.2174/1573396312666161213114223
2017-02-01
2024-11-14
Loading full text...

Full text loading...

/content/journals/cpr/10.2174/1573396312666161213114223
Loading

  • Article Type:
    Research Article
Keyword(s): Brain tumors; cancer; genetics; leukemia; lymphoma; pediatrics; retinoblastoma; wilms tumor
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test